Cardiff Oncology   Report issue

For profit Phase 2
Founded: San Diego CA United States (1999)

Organization Overview

First Clinical Trial
2017
NCT03303339
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Cardiff Oncology | Trovagene, Inc.